Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2024 Earnings Call Transcript February 19, 2025
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $1.52, expectations were $1.29.
Operator: Thank you for standing by, and welcome to the Krystal Biotech Q4 2024 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers’ presentations, there will be a question-and-answer session. As a reminder, today’s conference is being recorded. I would now like to hand...
